An interventional study of Micro needling then exosome application topically and Micro needling in Striae Distensae, sponsored by Tanta University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-11-05.
Sponsored by Tanta University · Not applicable, Interventional, and Treatment
This prospective comparative split-body study was carried out on 20 patients presenting with striae. All patients were subjected to full history taking, full general and dermatological examination, standared laboratory investigations, explanation of the procedure and possible side effects, patients signed a written informed consent. Digital photographs were taken before each session and monthly for 3 months after the end of treatment sessions. Each patient received three consecutive sessions two weeks apart.
Before the treatment sessions, patients were instructed to put topical anesthetic cream. During sessions, the treated areas were disinfected by alcohol 70%, microneedling was done on both sides with application of topical exosomes on the right side only. After sessions, a plastic wrap was put for one hour, patients were advised to put topical antibiotic twice daily for one week.
44 studies on the registry are indexed under Striae Distensae; 7 are open to participants now.
This study's enrollment of 20 is below the median of 30 across 43 interventional studies indexed under Striae Distensae.
Browse Striae Distensae studies →Tanta University is the lead sponsor of 1,010 studies on the registry; 321 are open to participants now.
Of its 15 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients who did not receive any treatment for their striae distensae for at least one month before joining the study.
Patients who accepted to be enrolled in the study and signed a written informed consen
Exclusion Criteria:
Procedure: Micro needling then exosome application topically
Procedure: Micro needling
Three sessions
Three sessions
Quartile grading scale
Three binded dermatologists evaluated the photographs taken before treatment, one month after the last session and after the follow up period (3 months after the last session). Physicians assessed the results using quartile grading scale which categorizes the improvement as follows: i. Excellent improvement: greater than 75%. ii. Very good improvement: 50-74%. iii.Good improvement: 25-49%. iv. Mild or poor improvement: less than 25%.
Time frame: Three months after last session
Plan to share: No
No publications or documents are linked to this record.
Ran from Jan 2025 to primary completion in Dec 2025, 11 months.
Of 22 interventional studies with no phase under Striae Distensae, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 58. This study's 11 months is below that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.